12-49295621-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006262.4(PRPH):c.421G>T(p.Asp141Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00542 in 1,545,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0036 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0056 ( 0 hom. )
Consequence
PRPH
NM_006262.4 missense
NM_006262.4 missense
Scores
2
10
6
Clinical Significance
Conservation
PhyloP100: 4.80
Genes affected
PRPH (HGNC:9461): (peripherin) This gene encodes a cytoskeletal protein found in neurons of the peripheral nervous system. The encoded protein is a type III intermediate filament protein with homology to other cytoskeletal proteins such as desmin, and is a different protein that the peripherin found in photoreceptors. Mutations in this gene have been associated with susceptibility to amyotrophic lateral sclerosis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0126363635).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRPH | NM_006262.4 | c.421G>T | p.Asp141Tyr | missense_variant | 1/9 | ENST00000257860.9 | NP_006253.2 | |
TROAP-AS1 | NR_120449.1 | n.2451C>A | non_coding_transcript_exon_variant | 6/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRPH | ENST00000257860.9 | c.421G>T | p.Asp141Tyr | missense_variant | 1/9 | 1 | NM_006262.4 | ENSP00000257860 | P1 | |
TROAP-AS1 | ENST00000553259.1 | n.2451C>A | non_coding_transcript_exon_variant | 6/8 | 2 | |||||
PRPH | ENST00000451891.4 | c.100-18G>T | intron_variant | 5 | ENSP00000408897 |
Frequencies
GnomAD3 genomes AF: 0.00360 AC: 548AN: 152220Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
548
AN:
152220
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00321 AC: 451AN: 140550Hom.: 0 AF XY: 0.00292 AC XY: 223AN XY: 76292
GnomAD3 exomes
AF:
AC:
451
AN:
140550
Hom.:
AF XY:
AC XY:
223
AN XY:
76292
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00562 AC: 7830AN: 1393228Hom.: 0 Cov.: 31 AF XY: 0.00531 AC XY: 3651AN XY: 687128
GnomAD4 exome
AF:
AC:
7830
AN:
1393228
Hom.:
Cov.:
31
AF XY:
AC XY:
3651
AN XY:
687128
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00360 AC: 549AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.00337 AC XY: 251AN XY: 74492
GnomAD4 genome
AF:
AC:
549
AN:
152336
Hom.:
Cov.:
33
AF XY:
AC XY:
251
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
TwinsUK
AF:
AC:
15
ALSPAC
AF:
AC:
26
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
42
ExAC
AF:
AC:
119
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2Other:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:1Other:1
not provided, no classification provided | literature only | Epithelial Biology; Institute of Medical Biology, Singapore | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2017 | - - |
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 16, 2017 | The D141Y variant in the PRPH gene has been reported previously in the homozygous and heterozygous state in unrelated individuals with ALS (Leung et al., 2004; Corrado et al., 2011). The D141Y variant is observed in 373/64280 (0.58%) alleles in the ExAC dataset, and no individuals were reported to be homozygous (Lek et al., 2016). The D141Y variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret D141Y as a variant of uncertain significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 31, 2023 | Variant summary: PRPH c.421G>T (p.Asp141Tyr) results in a non-conservative amino acid change located in the Intermediate filament, rod domain (IPR039008) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0032 in 140550 control chromosomes. This frequency does not allow conclusions about variant significance due to lack of accurate figures supporting the prevalence of PRPH-associated Amyotrophic Lateral Sclerosis Type 1 and limited reported association of this gene with the phenotype (Clingen, 2022). Furthermore, low to variable penetrance, role as a susceptibility factor and possibility of pre-symptomatic individuals in the control populations have each been speculated (Gromicho_2020). c.421G>T has been reported in the literature in individuals affected with features of Familial Amyotrophic Lateral Sclerosis (FALS) and in unaffected controls (example, Gromicho_2020). These report(s) do not provide unequivocal conclusions about association of the variant with Amyotrophic Lateral Sclerosis Type 1. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 32638105). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 (VUS, n=2; LB, n=1). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. - |
PRPH-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 21, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Amyotrophic lateral sclerosis, susceptibility to Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jul 01, 2004 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Benign
N
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at